Literature DB >> 11961230

Whatever happened to thrombopoietin?

David J Kuter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961230     DOI: 10.1046/j.1537-2995.2002.00056.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  6 in total

1.  A rationally designed agonist antibody fragment that functionally mimics thrombopoietin.

Authors:  Shana Frederickson; Mark W Renshaw; Bing Lin; Lynette M Smith; Peter Calveley; Jeremy P Springhorn; Krista Johnson; Yi Wang; Xiao Su; Yamin Shen; Katherine S Bowdish
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

Review 2.  The biology of thrombopoietin and thrombopoietin receptor agonists.

Authors:  David J Kuter
Journal:  Int J Hematol       Date:  2013-07-03       Impact factor: 2.490

Review 3.  Eltrombopag for use in children with immune thrombocytopenia.

Authors:  Taylor Olmsted Kim; Jenny Despotovic; Michele P Lambert
Journal:  Blood Adv       Date:  2018-02-27

Review 4.  Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag.

Authors:  Jemal Abdela
Journal:  Clin Med Insights Blood Disord       Date:  2019-10-21

5.  Intron V, not intron I of human thrombopoietin, improves expression in the milk of transgenic mice regulated by goat beta-casein promoter.

Authors:  Yan Li; Hu Hao; Mingqian Zhou; Hongwei Zhou; Jianbin Ye; Lijun Ning; Yunshan Ning
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

6.  Development of a sandwich enzyme-linked immunosorbent assay for dTMP-GH fusion protein by rational immunogen selection.

Authors:  Song Wang; Mingqiang Shen; Shilei Chen; Cheng Wang; Fang Chen; Mo Chen; Gaomei Zhao; Xinze Ran; Tianmin Cheng; Yongping Su; Yang Xu; Junping Wang
Journal:  AMB Express       Date:  2017-07-17       Impact factor: 3.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.